📰 Deep Phenotyping News

Page 2 - Deep Phenotyping News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Deep Phenotyping. Real-time updates on events, politics, business and more.

Heart failure patients may benefit from common type 2 diabetes drug

November 29, 2021

Dapagliflozin, a drug commonly used to treat type 2 diabetes, improved symptoms and physical limitations in patients with heart failure with preserved ejection fraction, according to clinical trial results published in Nature Medicine.

Sanjiv Shah Sadiya Khan Emily Henderson Institute For Augmented Intelligence In Medicine Division Of Cardiology Northwestern University

Source: news-medical.net

New machine-learning model can identify individuals at risk of rare cardiomyopathy

October 11, 2021

A machine-learning model can identify patients at risk of a rare cardiomyopathy, according to a study published in Nature Communications.

United States Sanjiv Shah Rahul Deo Emily Henderson Nature Communications American Heart Association

Source: news-medical.net

Northwestern receives $18.1M to study most common type of heart failure

October 6, 2021

Northwestern University Feinberg School of Medicine has been awarded two grants totaling $18.1 million to study the most common type of heart failure

Clyde Yancy Patrick Mccarthy Sanjiv Shah Denise Scholtens Abel Kho Sadiya Khan

Source: miragenews.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Page 2 - Deep Phenotyping News Today

Heart failure patients may benefit from common type 2 diabetes drug

New machine-learning model can identify individuals at risk of rare cardiomyopathy

Northwestern receives $18.1M to study most common type of heart failure

Explore More Categories